Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,391.79
-1.7%
$1,253.71
$850.51
▼
$1,475.25
$1.31T0.42.95 million shs1.02 million shs
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$66.53
-0.3%
$62.78
$51.20
▼
$68.92
$84.26B0.349.08 million shs3.05 million shs
Nestle SA stock logo
NSRGY
Nestle
$102.05
-0.9%
$97.47
$89.50
▼
$109.59
$262.93B0.42423,531 shs107,437 shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$39.49
-3.0%
$39.90
$35.12
▼
$64.16
$176.36B0.716.29 million shs7.83 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-1.29%-1.39%+12.29%+10.31%+38.04%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
-1.17%+0.32%+4.44%+4.04%+20.12%
Nestle SA stock logo
NSRGY
Nestle
-1.82%-2.02%+3.29%+3.75%+3.25%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-2.28%-0.08%+4.83%-12.39%-16.22%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,391.79
-1.7%
$1,253.71
$850.51
▼
$1,475.25
$1.31T0.42.95 million shs1.02 million shs
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$66.53
-0.3%
$62.78
$51.20
▼
$68.92
$84.26B0.349.08 million shs3.05 million shs
Nestle SA stock logo
NSRGY
Nestle
$102.05
-0.9%
$97.47
$89.50
▼
$109.59
$262.93B0.42423,531 shs107,437 shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$39.49
-3.0%
$39.90
$35.12
▼
$64.16
$176.36B0.716.29 million shs7.83 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-1.29%-1.39%+12.29%+10.31%+38.04%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
-1.17%+0.32%+4.44%+4.04%+20.12%
Nestle SA stock logo
NSRGY
Nestle
-1.82%-2.02%+3.29%+3.75%+3.25%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-2.28%-0.08%+4.83%-12.39%-16.22%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.83
Moderate Buy$1,422.000.66% Upside
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
2.63
Moderate Buy$69.303.83% Upside
Nestle SA stock logo
NSRGY
Nestle
2.25
HoldN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.00
Hold$59.4446.23% Upside

Current Analyst Ratings Breakdown

Latest NVO, LLY, MDLZ, and NSRGY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/17/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform$1,600.00
11/16/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,400.00 ➝ $1,550.00
11/13/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
UpgradeBuy (B) ➝ Buy (B+)
11/13/2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
UpgradeHold (C) ➝ Hold (C+)
11/13/2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Reiterated RatingBuy
11/12/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
DowngradeBuy ➝ Hold
11/9/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,610.00 ➝ $1,700.00
11/2/2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Reiterated RatingNeutral$72.00
11/2/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,440.00 ➝ $1,600.00
10/30/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
DowngradeBuy (B+) ➝ Buy (B)
10/30/2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Reiterated RatingHold (C)
(Data available from 11/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B20.39$24.80 per share56.95$42.81 per share33.00
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$38.54B2.19$3.97 per share16.83$21.06 per share3.17
Nestle SA stock logo
NSRGY
Nestle
$107.99B2.46$7.32 per share14.06$15.49 per share6.64
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.80B3.88$4.58 per share8.87$7.51 per share5.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$30.8145.8527.861.7131.90%86.76%22.03%2/3/2027 (Estimated)
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$2.45B$3.1721.0619.752.6910.22%14.18%5.21%2/2/2027 (Estimated)
Nestle SA stock logo
NSRGY
Nestle
$10.90BN/AN/A17.844.43N/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$3.9710.2411.781.4333.99%53.52%19.49%2/3/2027 (Estimated)

Latest NVO, LLY, MDLZ, and NSRGY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.71$7.48+$1.77$7.22$22.58 billion$24.40 billion
10/29/2026Q3 2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$0.7080$0.78+$0.0720$1.02$9.98 billion$9.97 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.49%+15.18%22.46%11 Years
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$2.083.12%+10.08%65.62%13 Years
Nestle SA stock logo
NSRGY
Nestle
$2.512.44%N/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.822.02%+21.74%20.65%N/A

Latest NVO, LLY, MDLZ, and NSRGY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/26/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.48%11/13/202611/13/202612/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.17
1.39
1.00
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.61
0.62
0.42
Nestle SA stock logo
NSRGY
Nestle
1.58
0.83
0.54
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.54
0.84
0.64

Institutional Ownership

CompanyInstitutional Ownership
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
78.32%
Nestle SA stock logo
NSRGY
Nestle
0.61%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.45%
Nestle SA stock logo
NSRGY
Nestle
N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000940.74 million939.43 millionOptionable
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
91,0001.27 billion1.26 billionOptionable
Nestle SA stock logo
NSRGY
Nestle
271,0002.58 billionN/ANot Optionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable

Recent News About These Companies

Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue
Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs.
Novo Nordisk Stock Rises on Obesity Drug Breakthrough

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,391.79 -23.76 (-1.68%)
As of 12:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Mondelez International stock logo

Mondelez International NASDAQ:MDLZ

$66.53 -0.23 (-0.34%)
As of 12:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe. It provides biscuits and baked snacks, including cookies, crackers, salted snacks, snack bars, and cakes and pastries; chocolates; and gums and candies, as well as various cheese and grocery, and powdered beverage products. The company's brand portfolio includes Oreo, Ritz, LU, CLIF Bar, and Tate's Bake Shop biscuits and baked snacks, as well as Cadbury Dairy Milk, Milka, and Toblerone chocolate. It serves supermarket chains, wholesalers, supercenters, club stores, mass merchandisers, distributors, convenience stores, gasoline stations, drug stores, value stores, and other retail food outlets through direct store delivery, company-owned and satellite warehouses, distribution centers, third party distributors, and other facilities, as well as through independent sales offices and agents. The company also sells products directly to businesses and consumers through e-retail platforms, retailer digital platforms, as well as through its direct-to-consumer websites and social media platforms. Mondelez International, Inc. was formerly known as Kraft Foods Inc. and changed its name to Mondelez International, Inc. in October 2012. The company was incorporated in 2000 and is headquartered in Chicago, Illinois.

Nestle stock logo

Nestle OTCMKTS:NSRGY

$102.05 -0.88 (-0.85%)
As of 11:53 AM Eastern

Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. The company operates through Zone North America; Zone Europe; Zone Asia, Oceania, and Africa; Zone Latin America; Zone Greater China; Nespresso; and Nestlé Health Science segments. It offers baby foods under the Cerelac, Gerber, Nido, and NaturNes brands; bottled water under the Nestlé Pure Life, Perrier, Vittel, Buxton, Erikli, and S.Pellegrino brands; cereals under the Fitness, Nesquik, cheerios, and Lion Cereals brands; and chocolate and confectionery products under the KitKat, Smarties, Aero, Nestlé Les Recettes de l'Atelier, Milkybar, Baci Perugina, Quality Street, and Fitness brands. The company provides coffee products under the Nescafé, Nespresso, Nescafé Dolce Gusto, Starbucks Coffee At Home, and Blue Bottle Coffee brands; culinary, chilled, and frozen foods under the Maggi, DiGiorno, Thomy, Garden Gourmet, Sweet Earth, Hot Pockets, Stouffer's, Buitoni, Lean, and Life Cuisine brands; dairy products under the Carnation, Nido, Bear, Coffee-Mate, and La Laitière brands; and drinks under the Nesquik, Nestea, Nescafé, and Milo brands. In addition, it offers food service products under the Milo, Nescafé, Maggi, Chef, Nestea, Stouffer's, Chef-Mate, Minor's, and Lean Cuisine brand names; healthcare nutrition products under the Boost, Garden of Life, Nature's Bounty, Persona, Vital Proteins, Solgar, Peptamen, Resource, Vitaflo, Impact, and Compleat brands; ice cream products under the Movenpick, Häagen-Dazs, Nestlé Ice Cream, and Extrême brands; and pet care products under the Purina, ONE, Alpo, Felix, Pro Plan, Cat Chow, Fancy Feast, Bakers, Friskies, Dog Chow, Beneful, and Gourmet brands. The company was founded in 1866 and is headquartered in Vevey, Switzerland.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$39.48 -1.22 (-2.99%)
As of 12:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.